Decitabine reduces transfusion dependence in older patients with acute myeloid leukemia: results from apost hocanalysis of a randomized phase III study
Authors:
- Liang XiuLXLiang Xiu
- Peter De PorrePPPeter De Porre
- Ramesh DassRDRamesh Dass
- Xavier ThomasXTXavier Thomas
- 30 October 2014
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 56 (4) , 1033-1042
Abstract
This post hoc analysis of the DACO-016 phase III study evaluates the impact of decitabine on transfusion dependence and survival in 485 elderly patients with newly diagnosed acute myeloid leukemia (AML). Red blood cell (RBC) and platelet (PLT) transfusion independence, defined as no transfusions for ≥ 8 consecutive weeks, was measured in both decitabine (n = 242) and treatment choice (TC, n = 243) arms. More RBC transfusion dependent patients at baseline became transfusion independent with decitabine than with TC (26% vs. 13%; p = 0.0026). Similar results were obtained for patients who were PLT transfusion dependent at baseline (31% vs. 13%; p = 0.0069). When excluding patients who attained complete remission (CR), survival was improved in patients who achieved RBC or PLT transfusion independence, suggesting that reaching CR is not a prerequisite for deriving benefit from treatment with decitabine. In addition, patients who achieved transfusion independence with decitabine had increased treatment continuation, even in the absence of CR.Keywords
This publication has 19 references indexed in Scilit:
- Boulevard of Broken Dreams: Drug Approval for Older Adults With Acute Myeloid LeukemiaJournal of Clinical Oncology, 2012
- Incidence, survival and prevalence of myeloid malignancies in EuropeEuropean Journal of Cancer, 2012
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaJournal of Clinical Oncology, 2012
- Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemiaHaematologica, 2012
- Treating the Elderly Patient with Acute Myelogenous LeukemiaHematology-American Society Hematology Education Program, 2010
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)Transplantation and Cellular Therapy, 2008
- Age and acute myeloid leukemiaBlood, 2006
- Transfusion independence in patients with myelodysplastic syndromesCancer, 2006
- Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision MakingJournal of Clinical Oncology, 2005